Navigation Links
CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
Date:5/20/2009

SAN MARINO, Calif., May 20 /PRNewswire-FirstCall/ -- On April 16, 2009 and March 18, 2009, biotechnology firm Viral Genetics, Inc. (Pink Sheets: VRAL) announced "that the company is pursing a promising new therapy for Lyme Disease with funding from Time for Lyme, Inc., and the Turn Corner Foundation." This correction is to clarify that those grants were not made to Viral Genetics but were made directly to the University of Colorado where Dr. M. Karen Newell is a tenured professor. The University then applied the funds to promising research into a treatment for Lyme Disease that is being conducted by Dr. M. Karen Newell and her research group at the University of Colorado. Any inference in the press releases that the grants were made directly to Viral Genetics rather than the university is incorrect.

Viral Genetics has certain exclusive licenses and options from the University of Colorado under previously filed patent rights, the work by Dr. Karen. Viral Genetics' license with the University is in return for certain obligations and fees.

Viral Genetics, Inc. is a biotechnology company that discovers and develops immune-based therapies for HIV, AIDS and other autoimmune diseases using its thymus nuclear protein compound (TNP). The company recently entered into an exclusive license agreement with the University of Colorado and V-Clip Pharmaceuticals (a subsidiary of the company) to license technology that appears to explain TNP and provide a means to optimize therapies based on TNP for future clinical trials. For more information, visit www.viralgenetics.com.

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetic
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Correction: Lawrence County Raw Milk Dairy Tests Negative for Campylobacter; Raw Milk Sales Resumed
2. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
3. Correction: Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
4. Correction: Therapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
5. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
6. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
7. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
8. Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013
9. World Health Assembly Forced to Postpone Decision on Viral Hepatitis
10. Viral Infection Might Trigger High Blood Pressure
11. Veterinarians at high risk for viral, bacterial infections from animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Conseco, Inc. (NYSE:,CNO) announced that Todd M. Hacker is ... president and treasurer. He will report to Ed,Bonach, Conseco,s ... Conseco from YRC Worldwide, where he was vice,president and ... From 2005-2006, he was senior vice president, finance and,administration, ...
... MCKINNEY, Texas, Jan. 8 Torchmark Corporation,(NYSE: TMK ... market,closes on Wednesday, February 6, 2008. In conjunction with ... listen to a,conference call that will be broadcast live ... a.m. Eastern. At that time a copy of the,Company,s ...
... HGR ) announced today that it plans to report ... on Monday, February 11,2008., The Company plans to issue ... 31, 2007 on Monday, February 11, 2008, after the,close of ... 9:00,a.m., EST, on Tuesday, February 12, 2008. Those wishing to ...
... LAKES, N.J., Jan. 8 Medco Health,Solutions, Inc. (NYSE: ... Jr. today,reiterated the company,s positive outlook for 2008 at ... The company reiterated its guidance for 2008 GAAP diluted ... assets that,existed when Medco became a publicly traded company, ...
... of developing breast cancer among people who carry the BRCA1 ... January 9/16 issue of JAMA. , BRCA1 and BRCA2 are ... magnitude of the risk of breast cancer in BRCA1 and ... options. The risk of breast cancer in BRCA1 and ...
... likely to undergo heart, liver and kidney transplantation , , TUESDAY, ... and rural areas are less likely to get organ transplants ... study found. , The study of almost 175,000 potential transplant ... percent to 15 percent less likely to be wait-listed and ...
Cached Medicine News:Health News:Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 2Health News:Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call 2Health News:Medco CEO Reiterates Guidance, Positive Outlook for 2008 2Health News:Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers 2Health News:Rural Residents Get Fewer Organ Transplants: Study 2Health News:Rural Residents Get Fewer Organ Transplants: Study 3
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ... IBD biology, human genetics, genomic technology, and drug ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ... clinical and aesthetic dermatology practitioners in the 21 st ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, ... and technologies must be able to protect ... (IP). (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ... nature of the Medical Device Industry, it ... industry sectors of cases involving IP infringement. ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~4.2 moles/vial and bovine factor Xa ~1.1...
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Medicine Products: